MedTrace Logo

Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia

NCT00003931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9769

Last updated 2016-07-04

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures, such as genetic testing, may improve the ability to detect acute myeloid leukemia and determine the extent of disease.

PURPOSE: Diagnostic study to try to detect changes in the genes of patients who have acute myeloid leukemia.

Conditions

Interventions

GENETIC

reverse transcriptase-polymerase chain reaction

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Michael A. Caligiuri, MD · Ohio State University Comprehensive Cancer Center

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-02-28
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003931 on ClinicalTrials.gov